Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial
- PMID: 21076131
- PMCID: PMC3093927
- DOI: 10.1093/rheumatology/keq234
Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial
Abstract
Objectives: To assess whether any benefits from adjunctive homeopathic intervention in patients with RA are due to the homeopathic consultation, homeopathic remedies or both.
Methods: Exploratory double-blind, randomized placebo-controlled trial conducted from January 2008 to July 2008, in patients with active stable RA receiving conventional therapy. Eighty-three participants from three secondary care UK outpatient clinics were randomized to 24 weeks of treatment with either homeopathic consultation (further randomized to individualized homeopathy, complex homeopathy or placebo) or non-homeopathic consultation (further randomized to complex homeopathy or placebo). Co-primary outcomes: ACR 20% improvement (ACR20) criteria and patient monthly global assessment (GA).
Secondary outcomes: 28-joint DAS (DAS-28), tender and swollen joint count, disease severity, pain, weekly patient and physician GA and pain, and inflammatory markers.
Results: Fifty-six completed treatment phase. No significant differences were observed for either primary outcome. There was no clear effect due to remedy type. Receiving a homeopathic consultation significantly improved DAS-28 [mean difference 0.623; 95% CI 0.1860, 1.060; P = 0.005; effect size (ES) 0.70], swollen joint count (mean difference 3.04; 95% CI 1.055, 5.030; P = 0.003; ES 0.83), current pain (mean difference 9.12; 95% CI 0.521, 17.718; P = 0.038; ES 0.48), weekly pain (mean difference 6.017; 95% CI 0.140, 11.894; P = 0.045; ES 0.30), weekly patient GA (mean difference 6.260; 95% CI 0.411, 12.169; P = 0.036; ES 0.31) and negative mood (mean difference - 4.497; 95% CI -8.071, -0.923; P = 0.015; ES 0.90).
Conclusion: Homeopathic consultations but not homeopathic remedies are associated with clinically relevant benefits for patients with active but relatively stable RA.
Trial registration: Current controlled trials, http://www.controlled-trials.com/, ISRCTN09712705.
Figures
Comment in
-
Homeopathy, non-specific effects and good medicine.Rheumatology (Oxford). 2011 Jun;50(6):1007-8. doi: 10.1093/rheumatology/keq265. Epub 2010 Nov 13. Rheumatology (Oxford). 2011. PMID: 21076130 No abstract available.
-
Comment 2 on: Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.Rheumatology (Oxford). 2011 Aug;50(8):1529-31; author reply author reply 1531-2. doi: 10.1093/rheumatology/ker120. Epub 2011 Jun 17. Rheumatology (Oxford). 2011. PMID: 21685464 No abstract available.
-
Comment 1 on: Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled trial.Rheumatology (Oxford). 2011 Aug;50(8):1529; author reply 1531-2. doi: 10.1093/rheumatology/ker109. Epub 2011 Jun 17. Rheumatology (Oxford). 2011. PMID: 21685465 No abstract available.
-
Clinical trial of homeopathy in rheumatoid arthritis.Homeopathy. 2011 Oct;100(4):300. doi: 10.1016/j.homp.2011.06.004. Homeopathy. 2011. PMID: 21962207 No abstract available.
References
-
- Hochberg MS, Spector TD. Epidemiology of rheumatoid arthritis: update. Epidemiological Rev. 1990;12:247–52. - PubMed
-
- Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effects of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double blind randomised controlled trial. Lancet. 2004;363:675–81. - PubMed
-
- Samarasekera U. Pressure grows against homoeopathy in the UK. Lancet. 2007;370:1677–8. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
